Results for Moderna

Add to feed Create your own feed

Latest

Column: Who made a mint from Moderna's premature vaccine announcement? Its execs who sold $29 million in stock within the next 2 days

Column: Who profited from Moderna's vaccine announcement? Its execs sold $29 million in stock afterwards:

Column: Moderna execs sold $29 million in stock after its early vaccine announcement

Shares of Moderna and Novavax, which have risen on positive vaccine developments, fall sharply in late trading.

Volunteer, 29, who got Moderna's experimental coronavirus jab had a 'severe reaction'

Moderna stock plummets after vaccine trial volunteer experiences bad reaction @moderna_tx  #ClamanCountdown 

The Tennessean's analysis showed Rep. Roe purchased stock in Zoom and Moderna, a leading company working on a coronavirus vaccine.

Column: Moderna execs sold $29 million in stock after its early vaccine announcement

Those Moderna $MRNA execs sure know how to time their stock sales. - #SlopeCharts  -

tweet picture

Loading
Loading

Most relevant

This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.

Moderna's stock price skyrocketed as much as 30% after the biotech company announced promising early results for its coronavirus vaccine. Then, two top executives dumped nearly $30 million in stocks.

Moderna's chief financial officer and chief medical officer executed options and sold nearly $30 million of shares combined on Monday and Tuesday, SEC filings reviewed by CNN Business show

Breaking News: The drug maker Moderna released promising, early results for a coronavirus vaccine in 8 healthy people, as it advances into accelerated phases of human trials

BREAKING: Moderna announces Phase 1 #COVID19  results: After two doses all patients in the trial developed antibodies for the virus @megtirrell  reports

JUST IN: Moderna has released promising early results for a coronavirus vaccine from a small trial — eight people tested were able to develop antibodies to neutralize the virus. The study will be moving to test on healthy volunteers this summer.

Moderna's early-stage human trial for a coronavirus vaccine produced antibodies in all 45 participants.

Moderna Therapeutics, a biotech company based in Cambridge, Mass., has shipped the first batches of its COVID-19 vaccine

Moderna Therapeutics, a biotech company based in Cambridge, Mass., has shipped the first batches of its COVID-19 vaccine

Moderna Therapeutics, a biotech company based in Cambridge, Mass., has shipped the first batches of its COVID-19 vaccine

Loading
Loading